Price $1.54 |
Market Cap
145.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.02
|
P/S
163.1
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-54.1K
|
FCF
-0.6
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-105.70%
|
ROI
-74.70%
|
|
ROA
-75.20%
|
EPS Growth
-93.60%
|
Current Ratio
7.7
|
Debt/Equity
33.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Medicure Inc (MCUJF) | $0.93 | - | - | 10.2M | Strong Buy |
| Natus Medical Inc (NTUS) | $27.49 | - | - | 906.5M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $5.96 | - | - | 1.68B | Strong Buy |
| Myriad Genetics, Inc. (MYGN) | $29.73 | - | - | 2.23B | Strong Buy |
| IntriCon Corporation (IIN) | $21.61 | - | - | 210.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
